Novartis AG ADR Stock
€104.00
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Novartis
sharewise wants to provide you with the best news and tools for Novartis, so we directly link to the best financial data sources.
Financials
News
Novartis Ag (NVS) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Novartis Ag (NYSE: NVS)Q2 2024 Earnings CallJul 18, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Why Novartis Stock Is Down Today Despite Topping Q2 Estimates
By most standards shares of drugmaker Novartis (NYSE: NVS) should be higher following this morning's release of its second-quarter results. The drugmaker's top and bottom lines were both better than
2 Magnificent Dividend Stocks to Hold for the Next Decade
There are many reasons to invest in excellent dividend stocks. Such investments are often worth the trouble regardless of whether you're investing for the dividend, or for making capital gains from
Why Novartis Stock Topped the Market on Tuesday
Scooting past analyst estimates for its latest quarter gave Novartis (NYSE: NVS) a lift on Tuesday. Investors like what they heard about the global healthcare company's inaugural earnings release
Novartis Ag (NVS) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Novartis Ag (NYSE: NVS)Q1 2024 Earnings CallApr 23, 2024, 8:00 a.m. ET
Operator
Source Fool.com
2 High-Yield Dividend Stocks to Buy and Hold for 10 Years
Great dividend stocks don't always have particularly high yields. Still, it's nice to see a solid income stock that boasts one that's higher than average. And if this company can reward its
1 Magnificent Dividend Stock to Buy and Hold
There are plenty of dividend stocks on the market. However, some raise their payouts irregularly, while others don't have businesses that look robust enough to support payout growth for a long time
Pharma Leader Beats on Earnings, But Shares Fall
Novartis (NYSE:NVS) is the seventh largest pharmaceutical company in the world, and is based in Switzerland. The firm reported Q2 2024 financial results on Jul. 18, 2024. The company is performing
